101
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Physical Activity versus Sclerostin and Interleukin 6 Concentration in Patients Receiving Renal Replacement Therapy by Hemodialysis

, , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1467-1475 | Published online: 07 Sep 2020

References

  • Barcellos FC, Santos IS, Umpierre D, Bohlke M, Hallal PC. Effects of exercise in the whole spectrum of chronic kidney disease: a systematic review. Clin Kidney J. 2015;8(6):753–765. doi:10.1093/ckj/sfv09926613036
  • Brandenburg VM, D’Haese P, and Deck A, et al. From skeletal to cardiovascular disease in 12 steps – the evolution of sclerostin as a major player in CKD-MBD. Pediatr Nephrol. 2016;31(2):195–206. doi:10.1007/s00467-015-3069-725735207
  • Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10(9):504–516. doi:10.1038/nrneph.2014.11224981816
  • Xiong L, Jung J-U, Wu H, et al. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. Proc Natl Acad Sci. 2015;112(11):3487–3492. doi:10.1073/pnas.141971411225733894
  • Bonani M, Rodriguez D, Fehr T, et al. Sclerostin blood levels before and after kidney transplantation. Kidney Blood Press Res. 2014;39(4):230–239. doi:10.1159/00035578125118597
  • Brown JP, Albert CA, Nassar BA, et al. Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem. 2009;42(10–11):929–942. doi:10.1016/j.clinbiochem.2009.04.00119362543
  • Desjardins L, Liabeuf S, Oliveira RB, et al. Uremic toxicity and sclerostin in chronic kidney disease patients. Nephrol Ther. 2014;10(6):463–470. doi:10.1016/j.nephro.2014.04.00225070604
  • Evenepoel P, Claes K, and Viaene L, et al. Decreased circulating sclerostin levels in renal transplant recipients with persistent hyperparathyroidism. Transplantation. 2016;100(10):2188–2193. doi:10.1097/TP.000000000000131127379556
  • Jean G, Chazot C, Bresson E, Zaoui E, and Cavalier E. High serum sclerostin levels are associated with a better outcome in haemodialysis patients. Nephron. 2016;132(3):181–190. doi:10.1159/00044384526890570
  • Moysés RMA, Jamal SA, Graciolli FG, Dos Reis LM, Elias RM. Can we compare serum sclerostin results obtained with different assays in hemodialysis patients? Int Urol Nephrol. 2015;47(5):847–850. doi:10.1007/s11255-015-0971-725862239
  • Buczko W, Danysz A. Kompendium Farmakologii i Farmakoterapii. Wyd.6 Wrocław: edra Urban&Partner; 2016 ISBN: 978-83-65373-27-4.
  • Gołąb J, Jakóbisiak M, Lasek W, Stokłosa T. Immunologia. Wyd.7. Warszawa: wydawnictwo Naukowe PWN; 2017 ISBN: 9788301194505.
  • Mutschler E, Geisslinger G, Kroemer HK, et al.: Mutschler - farmakologia i toksykologia. Podręcznik. Wrocław: medPharm Polska; 2016 ISBN: 9788378460374.
  • Dungey M, Young HML, Churchward DR, Burton JO, Smith AC, Bishop NC. Regular exercise during haemodialysis promotes an anti-inflammatory leucocyte profile. Clin Kidney J. 2017;10(6):813–821. doi:10.1093/ckj/sfx01529225811
  • Turoń-Skrzypinska A, Dutkiewicz G, and Marchelek-Mysliwiec M. Assessment of sclerostin and interleukin 6 levels and selected anthropometric parameters in patients receiving hemodialysis replacement therapy – pilot study. Medicina. 2019;55(12):15. doi:10.3390/medicina55120784
  • Hiraki K, Shibagaki Y, Izawa KP, et al. Effects of home-based exercise on pre-dialysis chronic kidney disease patients: a randomized pilot and feasibility trial. BMC Nephrol. 2017;18(1):198. doi:10.1186/s12882-017-0613-728623895
  • Akber A, Portale AA, Johansen KL. Use of pedometers to increase physical activity among children and adolescents with chronic kidney disease. Pediatr Nephrol. 2014;29(8):1395–1402. doi:10.1007/s00467-014-2787-624648129
  • Hanan M, and Bronas U. Barriers to exercise for patients with renal disease: an integrative review. J Nephrol. 2017;30(6):729–741. doi:10.1007/s40620-017-0420-z28689231
  • Jhamb M, McNulty M, and Ingalsbe G, et al. Knowledge, barriers and facilitators of exercise in dialysis patients: a qualitative study of patients, staff and nephrologists. BMC Nephrol. 2016;17(1):192. doi:10.1186/s12882-016-0399-z27881101
  • Hornik B, Janusz-Jenczeń M, Włodarczyk I. Przestrzeganie zaleceń aktywności fizycznej przez chorych hemodializowanych Dybińska E, Szpringer M, Asienkiewicz R, editors. Profilaktyka I Edukacja Zdrowotna. Lublin: Wydawnictwo Naukowe Neurocentrum. 2017 109–122. ISBN: 978-83-61495-79-6.
  • Storer TW. Exercise Training for Individuals with Advanced Chronic Kidney Disease In: Joel D, editor. Nutritional Management of Renal Disease. 3rd ed. Amsterdam: Academic Press; 2013:739–773.
  • Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015;175(6):959–967. doi:10.1001/jamainternmed.2015.053325844730
  • Nowicki M, Murlikiewicz K, Jagodzińska M. Pedometers as a means to increase spontaneous physical activity in chronic hemodialysis patients. J Nephrol. 2010;23(3):297–305.20301085
  • Brończyk-Puzoń A, Koszowska A, Bieniek J, Podstawowe pomiary antropometryczne i pochodne wskaźniki w poradnictwie dietetycznym – część pierwsza. Piel Zdr Publ. 2018;8:217–222. doi:10.17219/pzp/92366
  • Drozdowski Z. Antropometria w wychowaniu fizycznym. Wyd. 4 zm i uzup. Poznań: akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu. 1998 ISBN: 83-86336-51-X.
  • Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011;10:CD003236. doi:10.1002/14651858.CD003236.pub2
  • Anding K, Bär T, Trojniak-Hennig J, et al. A structured exercise programme during haemodialysis for patients with chronic kidney disease: clinical benefit and long-term adherence. BMJ Open. 2015;5(8):e008709. doi:10.1136/bmjopen-2015-008709
  • Manfredini F, Mallamaci F, and D’Arrigo G, et al. Exercise in patients on dialysis: a multicenter, randomized clinical trial. J Am Soc Nephrol. 2017;28(4):1259–1268. doi:10.1681/ASN.201603037827909047
  • Baggetta R, D’Arrigo G, Torino C, et al. Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial. BMC Geriatr. 2018;18(1):248. doi:10.1186/s12877-018-0938-530342464
  • Cook WL, Jassal SV. Functional dependencies among the elderly on hemodialysis. Kidney Int. 2008;73(11):1289–1295. doi:10.1038/ki.2008.6218354381
  • Weber-Nowakowska K, Gębska M, Myślak M, Żyżniewska-Banaszak E, Stecko M. Rola aktywności fizycznej w leczeniu pacjentów z przewlekłą chorobą nerek. Pomeranian J Life Sci. 2017;63:27–30. doi:10.21164/pomjlifesci.247
  • Johansen KL, Chertow GM, Ng AV, et al. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int. 2000;57(6):2564–2570. doi:10.1046/j.1523-1755.2000.00116.x10844626
  • Kutner NG, Zhang R, Huang Y, and Johansen KL. Depressed mood, usual activity level, and continued employment after starting dialysis. Clin J Am Soc Nephrol. 2010;5(11):2040–2045. doi:10.2215/CJN.0398051020884777
  • Delgado C, Johansen KL. Barriers to exercise participation among dialysis patients. Nephrol Dial Transplant. 2012;27(3):1152–1157. doi:10.1093/ndt/gfr40421795245
  • Wojczyk A. Problemy codziennego życia hemodializowanych pacjentów. Piel Zdr Publ. 2014;4:143–148.
  • Goodman ED, Ballou MB. Perceived barriers and motivators to exercise in hemodialysis patients. Nephrol Nurs J. 2004;31(1):23–29.15008071
  • Jayaseelan G, Bennett PN, Bradshaw W, Wang W, and Rawson H. Exercise benefits and barriers: the perceptions of people receiving hemodialysis. Nephrol Nurs J. 2018;45(2):185–219.30303639
  • Nowicki M, Jagodzińska M, Murlikiewicz K, Niewodniczy M. Aktywność fizyczna chorych przewlekle dializowanych – porównanie skuteczności różnych metod jej zwiększania. Post Nauk Med. 2009;10:799–804.
  • Cobo G, Gallar P, Gama-Axelsson T, et al. Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients. J Nephrol. 2015;28(4):503–510. doi:10.1007/s40620-014-0164-y25501981
  • Gombos GC, Bajsz V, Pék E, et al. Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass. BMC Musculoskelet Disord. 2016;17(1). doi:10.1186/s12891-016-1109-5
  • Janik M, Stuss M, Michalska-Kasiczak M, Jegier A, Sewerynek E. Effects of physical activity on sclerostin concentrations. Endokrynol Pol. 2018;69(2):142–149. doi:10.5603/EP.a2018.000829465155
  • Ardawi MSM, Al-Kadi HA, Rouzi AA, Quari MH. Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res. 2011;26(12):2812–2822. doi:10.1002/jbmr.47921812027
  • Frings-Meuthen P, Boehme G, Liphard A-M, Baecker N, Heer M. Rittweger J. Sclerostin and DKK1 levels during 14 and 21 days of bed rest in healthy young men. J Musculoskelet Neuronal Interact. 2013;13(1):45–52.23445914
  • Gaudio A, Pennisi P, Bratengeier C, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010;95(5):2248–2253. doi:10.1210/jc.2010-006720305005
  • Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77–90. doi:10.1053/j.jrn.2013.01.00123428357
  • Stenvinkel P, Ketteler M, and Johnson RJ, et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia – the good, the bad, and the ugly. Kidney Int. 2005;67(4):1216–1233. doi:10.1111/j.1523-1755.2005.00200.x15780075
  • Cheema BSB, Abas H, Smith BCF, et al. Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial. Eur J Appl Physiol. 2011;111(7):1437–1445. doi:10.1007/s00421-010-1763-521161265
  • Daniilidis M, Kouidi E, Giagoudaki F, et al. The immune response in hemodialysis patients following physical training. Sport Sci Health. 2004;1(1):11–16. doi:10.1007/s11332-004-0003-y
  • Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45(10):1563–1569. doi:10.1016/j.jacc.2004.12.07715893167
  • Colbert LH, Visser M, and Simonsick EM, et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study. J Am Geriatr Soc. 2004;52(7):1098–1104. doi:10.1111/j.1532-5415.2004.52307.x15209647
  • Hamer M, Sabia S, Batty GD, et al. Physical activity and inflammatory markers over 10 years follow up in men and women from the Whitehall II cohort study. Circulation. 2012;126(8):928–933. doi:10.1161/CIRCULATIONAHA.112.10387922891048
  • Huang JH, Li RH., Huang SL, Sia HK, Hsu WT, Tang FC. Health-Associated Nutrition and. Exercise Behaviors in Relation to Metabolic Risk Factors Stratified by Body Mass Index. Int J Environ Res Public Health. 2019;16(5). doi:10.3390/ijerph16050869
  • Fujino Y, Ishimura E, Okuno S, et al. Annual fat mass change is a significant predictor of mortality in female hemodialysis patients. Biomed Pharmacother. 2006;60(5):253–257. doi:10.1016/j.biopha.2006.04.00116740375
  • McPhee J, French D, Jackson D, Nazroo J, Pendleton N, Degens H. Physical activity in older age: perspectives for healthy ageing and frailty. Biogerontology. 2016;17(3):567–580. doi:10.1007/s10522-016-9641-026936444